These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30314914)

  • 1. Anti-inflammatory agents reduce microglial response, demyelinating process and neuronal toxin uptake in a model of encephalopathy produced by Shiga Toxin 2.
    Pinto A; Berdasco C; Arenas-Mosquera D; Cangelosi A; Geoghegan PA; Nuñez MC; Goldstein J
    Int J Med Microbiol; 2018 Dec; 308(8):1036-1042. PubMed ID: 30314914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Deficits Found in a Pro-inflammatory State are Independent of ERK1/2 Signaling in the Murine Brain Hippocampus Treated with Shiga Toxin 2 from Enterohemorrhagic Escherichia coli.
    Berdasco C; Pinto A; Blake MG; Correa F; Carbajosa NAL; Celi AB; Geoghegan PA; Cangelosi A; Nuñez M; Gironacci MM; Goldstein J
    Cell Mol Neurobiol; 2023 Jul; 43(5):2203-2217. PubMed ID: 36227397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone prevents motor deficits and neurovascular damage produced by shiga toxin 2 and lipopolysaccharide in the mouse striatum.
    Pinto A; Cangelosi A; Geoghegan PA; Goldstein J
    Neuroscience; 2017 Mar; 344():25-38. PubMed ID: 28042026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex.
    Pinto A; Jacobsen M; Geoghegan PA; Cangelosi A; Cejudo ML; Tironi-Farinati C; Goldstein J
    PLoS One; 2013; 8(7):e70020. PubMed ID: 23894578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental Cues Modulate Microglial Cell Behavior Upon Shiga Toxin 2 From Enterohemorrhagic
    Berdasco C; Duhalde Vega M; Rosato-Siri MV; Goldstein J
    Front Cell Infect Microbiol; 2019; 9():442. PubMed ID: 31970091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga toxin 2 from enterohemorrhagic Escherichia coli induces reactive glial cells and neurovascular disarrangements including edema and lipid peroxidation in the murine brain hippocampus.
    Berdasco C; Pinto A; Calabró V; Arenas D; Cangelosi A; Geoghegan P; Evelson P; Goldstein J
    J Biomed Sci; 2019 Feb; 26(1):16. PubMed ID: 30732602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
    Dammermann W; Mihajlov V; Middendorf B; Mellmann A; Karch H; Lüth S; Ullrich S
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1353-1356. PubMed ID: 29280264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A translational murine model of sub-lethal intoxication with Shiga toxin 2 reveals novel ultrastructural findings in the brain striatum.
    Tironi-Farinati C; Geoghegan PA; Cangelosi A; Pinto A; Loidl CF; Goldstein J
    PLoS One; 2013; 8(1):e55812. PubMed ID: 23383285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
    Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
    Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains.
    Boccoli J; Loidl CF; Lopez-Costa JJ; Creydt VP; Ibarra C; Goldstein J
    Brain Res; 2008 Sep; 1230():320-33. PubMed ID: 18675791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-(1-7) protects from brain damage induced by shiga toxin 2-producing enterohemorrhagic Escherichia coli.
    Goldstein J; Carden TR; Perez MJ; Taira CA; Höcht C; Gironacci MM
    Am J Physiol Regul Integr Comp Physiol; 2016 Dec; 311(6):R1173-R1185. PubMed ID: 27681328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines expression from altered motor thalamus and behavior deficits following sublethal administration of Shiga toxin 2a involve the induction of the globotriaosylceramide receptor.
    Arenas-Mosquera D; Pinto A; Cerny N; Berdasco C; Cangelosi A; Geoghegan PA; Malchiodi EL; De Marzi M; Goldstein J
    Toxicon; 2022 Sep; 216():115-124. PubMed ID: 35835234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal administration of Shiga toxin 2 induced neuronal alterations and reduced the expression levels of aquaporin 1 and aquaporin 4 in rat brain.
    Lucero MS; Mirarchi F; Goldstein J; Silberstein C
    Microb Pathog; 2012 Aug; 53(2):87-94. PubMed ID: 22610042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo.
    Li T; Tu W; Liu Y; Zhou P; Cai K; Li Z; Liu X; Ning N; Huang J; Wang S; Huang J; Wang H
    Sci Rep; 2016 Feb; 6():21837. PubMed ID: 26903273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with BLS-Stx2B chimera totally protects dams from early pregnancy loss induced by Shiga toxin type 2 (Stx2) and confers anti-Stx2 immunity to the offspring.
    Sacerdoti F; Mejías MP; Bruballa AC; Alvarez RS; Amaral MM; Palermo MS; Ibarra C
    Vaccine; 2016 Sep; 34(39):4732-4737. PubMed ID: 27527816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities.
    Tironi-Farinati C; Loidl CF; Boccoli J; Parma Y; Fernandez-Miyakawa ME; Goldstein J
    J Neuroimmunol; 2010 May; 222(1-2):48-61. PubMed ID: 20347160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch Belted rabbits.
    García A; Marini RP; Catalfamo JL; Knox KA; Schauer DB; Rogers AB; Fox JG
    Microbes Infect; 2008 May; 10(6):650-6. PubMed ID: 18462972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
    Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
    Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Enterohemorrhagic Escherichia coli-Induced Acute Encephalopathy and Hemolytic-Uremic Syndrome With Polymyxin-B Direct Hemoperfusion.
    Kaneda H; Shimizu M; Yachie A
    Ther Apher Dial; 2017 Aug; 21(4):419-421. PubMed ID: 28597511
    [No Abstract]   [Full Text] [Related]  

  • 20. Uncommon Shiga toxin-producing Escherichia coli serotype O165:HNM as cause of hemolytic uremic syndrome in São Paulo, Brazil.
    de Souza RL; Nishimura LS; Guth BE
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):223-5. PubMed ID: 17662558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.